Industry News
Potential test for diabetes in children
UQ researchers are developing a predictive test for type 1 diabetes by tracing activation of the NF-kappa B pathway. [ + ]
Australia and New Zealand on display at Pittcon
What's New in LAB Technology editor Janette Woodhouse reports on the Australian contingent at Pittcon 2008.
[ + ]Blackburn picks up accolades and tidy sum
Elizabeth Blackburn accepts her L'Oreal women in science award in Paris. [ + ]
Pittcon is driving on bio-diesel
Many companies release their latest products at Pittcon. This year, as part of the swing away from biotechnology and towards environmental sustainability testing, there is an abundance of bio-diesel and bio-fuel analysers hitting the market.
[ + ]Qld opens tumour-cell testing facility
More effective treatments for brain cancer will be developed at a tumour-cell testing facility opened yesterday at The University of Queensland’s Queensland Brain Institute.
[ + ]Key steps in apoptosis
US researchers discover how certain proteins control the process of programmed cell death. [ + ]
Biotechnology appears to be dead
Biotechnology seems to have taken a back seat this year at Pittcon, the huge annual laboratory conference and exposition held in the US.
[ + ]Artificial 'cells' boost immune response
US researchers design artificial antigen-presenting cells to boost T cell proliferation. [ + ]
BRCA genes and ovarian cancer
David Bowtell is investigating the role of BRCA1 and BRCA2 in ovarian cancer. [ + ]
National Science Week grants announced
The National Science Week grants were announced on Tuesday, with $500,000 in funding provided to one of the most diverse sets of projects in the program's 11-year history.
[ + ]WEHI joins Abbott and Genentech
Melbourne's WEHI partners Abbott and Genentech in new drug discovery program. [ + ]
Another notch in the pathway
Notch controls bone formation and strength as well as cell differentiation [ + ]
New ERA for research quality
Science minister Kim Carr announces replacement for dumped RQF. [ + ]
Bionomics begins Phase 1 trial
The first patients have begun treatment in Bionomics' Phase 1 trial of its vascular disruption agent. [ + ]
Australians honoured for 'best research of the year'
Gene research involving scientists at the University of Queensland’s (UQ) Diamantina Institute for Cancer, Immunology and Metabolic Medicine has received high acclaim by leading scientific journals Science and Nature.
[ + ]
